MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

27.74 -0.72

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

27.07

Max

27.82

Põhinäitajad
By Trading Economics
Sissetulek	-28M 22M
Müük	4.3M 244M
P/E Sektori keskmine	9.926 56.063
Kasumimarginaal	9.224
Töötajad	293
EBITDA	-22M 52M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+47.27% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	8.3M 1.6B
Eelmine avamishind	28.46
Eelmine sulgemishind	27.74

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2026, 17:11 UTC

Suurimad hinnamuutused turgudel

Uudisväärsed sündmused

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2. apr 2026, 17:10 UTC

Uudisväärsed sündmused

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

2. apr 2026, 23:47 UTC

Market Talk

Uudisväärsed sündmused

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2. apr 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2. apr 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2. apr 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2. apr 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2. apr 2026, 21:01 UTC

Uudisväärsed sündmused

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2. apr 2026, 20:59 UTC

Omandamised, ülevõtmised, äriostud

Starbucks and Boyu Capital Finalize China JV

2. apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. apr 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

2. apr 2026, 20:41 UTC

Tulu

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2. apr 2026, 20:32 UTC

Market Talk

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2. apr 2026, 20:30 UTC

Omandamised, ülevõtmised, äriostud

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. apr 2026, 20:09 UTC

Market Talk

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2. apr 2026, 20:01 UTC

Omandamised, ülevõtmised, äriostud

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. apr 2026, 19:46 UTC

Market Talk

Is Oil the New GameStop? -- Market Talk

2. apr 2026, 19:35 UTC

Market Talk

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2. apr 2026, 19:29 UTC

Omandamised, ülevõtmised, äriostud

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. apr 2026, 19:24 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2. apr 2026, 19:20 UTC

Market Talk

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2. apr 2026, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2. apr 2026, 19:00 UTC

Omandamised, ülevõtmised, äriostud

Union Pacific: Agreement Reached With American Train Dispatchers Association

2. apr 2026, 18:24 UTC

Omandamised, ülevõtmised, äriostud

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2. apr 2026, 17:44 UTC

Market Talk

Uudisväärsed sündmused

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2. apr 2026, 17:32 UTC

Uudisväärsed sündmused

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2. apr 2026, 17:26 UTC

Tulu

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2. apr 2026, 17:17 UTC

Market Talk

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2. apr 2026, 17:09 UTC

Market Talk

Uudisväärsed sündmused

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

2. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

47.27% tõus

12 kuu keskmine prognoos

Keskmine 41.25 USD 47.27%

Kõrge 62 USD

Madal 25 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

Osta

Hoia

Müü

Põhineb 8 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.